Bone metabolism during anti‐thyroid drug treatment of endogenous subclinical hyperthyroidism

Abstract

Treatment with methimazole in post-menopausal women with endogenous subclinical hyperthyroidism associated with multinodular goitre can prevent excessive loss of bone, at least in the distal forearm.